I guess the market is shifting its view on NCE. Patents "520 and "569 give vascepa some good protection. If one of the analysts confirm this thinking, stock price will trade above $10 in the near term.
Oh yeah highstyle unfortunately while the move up on NCE ganted will be in dollars it works both ways but one thing is for sure the market is still patiently waiting just like us for that decision and will take her up or down accordingly.
If you think this price action is inidicative of the market feeling NCE is not important anymore think again mojambo wait and see what happens if NCE is granted the move will be in dollars not pennies you can take that to the bank!!!
-Composition of pure EPA 90% - 95% patented to 2021
-Method of treating very High TGs with pure EPA to 2030
-Stable EPA in package till 2030
-Method of treating high TGs with pure EPA to 2030
-Suppliers of API locked with exclusivity contracts
Patents in pipe
- AMR102 combo with Statin
- Vascepa with CV drugs ( every one)
- More Comosition patents
- More Stable EPA Patents